指南与共识心血管USMRPET

恰加斯病的多模态影像学评估:巴西心血管影像部(DIC)与欧洲心血管影像协会(EACVI)专家共识

Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI).
指南 / 共识 · Eur Heart J Cardiovasc Imaging · 2018-01-01

该专家共识由巴西心血管影像部与欧洲心血管影像协会制定,系统回顾恰加斯病无创心血管影像评估证据,提出标准化影像框架以评估心脏形态与功能异常并指导临床决策。共识强调超声心动图是评估和随访最常用方法,心脏磁共振、核素心室造影和心肌灌注显像在特定情形下有补充价值。

要点

  • 超声心动图是评估和随访恰加斯病最常用的影像方法,异常出现可用于疾病分期。
  • 早期心脏受累可表现为节段性左室壁运动异常,主要位于下壁、下侧壁基底段和心尖,不能归因于 obstructive 冠状动脉。
  • 三维超声心动图在评估左室心尖部、心尖室壁瘤和血栓方面优于常规二维超声心动图。

核心结论

  • 心脏影像对检测恰加斯病心脏受累、疾病分期、风险分层和指导管理至关重要。
  • 大多数患者生活在影像方法可及性有限的地区,床旁简化方案可改善偏远人群获取影响临床管理的重要信息。
  • 恰加斯病心脏影像仍有许多领域需进一步研究,如何更好提供心脏受累的早期诊断并改善患者风险分层尚待解决。

研究设计与样本

  • 巴西心血管影像部(DIC)与欧洲心血管影像协会(EACVI)制定的专家共识文件,旨在回顾和总结恰加斯病无创评估的最新证据。
  • 共识意图建立标准化心血管影像框架,以评估心血管形态和功能异常,并指导后续临床决策过程。

关键影像表现/征象

  • 早期心脏受累时,超声心动图可显示节段性左室壁运动异常,主要位于下壁、下侧壁基底段和心尖,不能归因于 obstructive 冠状动脉。
  • 节段性室壁运动异常患病率随疾病分期变化,在左室扩张和功能障碍患者中可达约50%。
  • 舒张功能障碍是恰加斯病的重要标志,即使早期阶段也存在;左室舒张和收缩功能障碍通常共存,孤立性舒张功能障碍不常见但可见于 indeterminate 型。
  • 右室功能障碍可在疾病早期被检测到,但临床表现一般出现于恰加斯心肌病晚期。

诊断标准与关键数值

  • 二维超声心动图怀疑心室缩短时,三维超声心动图可更准确评估左室心尖部,从而检测心尖室壁瘤和血栓。
  • 三维超声心动图在评估有明显室壁运动异常(包括几何变形的室壁瘤)患者的左室容积和功能方面,比二维Simpson双平面法更准确。
  • 超声心动图参数用于评估右室功能,包括定性评估、心肌性能指数、组织多普勒成像、三尖瓣环收缩期位移和斑点追踪应变。

临床应用与阅片要点

  • 超声心动图是评估和随访恰加斯病患者最常用的影像方法,出现超声心动图异常对疾病分期至关重要。
  • 斑点追踪超声心动图可更精确和定量测量区域心肌功能,在节段性室壁运动异常常见的恰加斯病中可能有重要临床应用,尤其在不确定型异常更细微时。
  • 斑点追踪超声心动图可量化收缩异质性,与心律失常事件风险相关。
  • 对比超声心动图可增强左室心内膜边界,从而更准确检测恰加斯病中的心室室壁瘤和血栓。
  • 心脏磁共振可用于评估恰加斯病患者整体和区域左室功能,晚期钆增强用于检测和定量心肌纤维化。

局限性

  • 关于心脏磁共振评估恰加斯病右室功能的数据有限。
  • 大多数患者生活在影像方法可及性有限的地区。
  • 恰加斯病心脏影像仍有许多领域需进一步研究,如何更好提供心脏受累的早期诊断并改善患者风险分层尚待解决。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIMS: To develop a document by Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI) to review and summarize the most recent evidences about the non-invasive assessment of patients with Chagas disease, with the intent to set up a framework for standardized cardiovascular imaging to assess cardiovascular morphologic and functional disturbances, as well as to guide the subsequent process of clinical decision-making.

METHODS AND RESULTS: Chagas disease remains one of the most prevalent infectious diseases in Latin America, and has become a health problem in non-endemic countries. Dilated cardiomyopathy is the most severe manifestation of Chagas disease, which causes substantial disability and early mortality in the socially most productive population leading to a significant economical burden. Prompt and correct diagnosis of Chagas disease requires specialized clinical expertise to recognize the unique features of this disease. The appropriate and efficient use of cardiac imaging is pivotal for diagnosing the cardiac involvement in Chagas disease, to stage the disease, assess patients' prognosis and address management. Echocardiography is the most common imaging modality used to assess, and follow-up patients with Chagas disease. The presence of echocardiographic abnormalities is of utmost importance, since it allows to stage patients according to disease progression. In early stages of cardiac involvement, echocardiography may demonstrate segmental left ventricuar wall motion abnormalities, mainly in the basal segments of inferior, inferolateral walls, and the apex, which cannot be attributed to obstructive coronary artery arteries. The prevalence of segmental wall motion abnormalities varies according to the stage of the disease, reaching about 50% in patients with left ventricular dilatation and dysfunction. Speckle tracking echocardiography allows a more precise and quantitative measurement of the regional myocardial function. Since segmental wall motion abnormalities are frequent in Chagas disease, speckle tracking echocardiography may have an important clinical application in these patients, particularly in the indeterminate forms when abnormalities are more subtle. Speckle tracking echocardiography can also quantify the heterogeneity of systolic contraction, which is associated with the risk of arrhythmic events. Three-dimensional (3D) echocardiography is superior to conventional two-dimensional (2D) echocardiography for assessing more accurately the left ventricular apex and thus to detect apical aneurysms and thrombus in patients in whom ventricular foreshortening is suspected by 2D echocardiography. In addition, 3D echocardiography is more accurate than 2D Simpson s biplane rule for assessing left ventricular volumes and function in patients with significant wall motion abnormalities, including aneurysms with distorted ventricular geometry. Contrast echocardiography has the advantage to enhancement of left ventricular endocardial border, allowing for more accurate detection of ventricular aneurysms and thrombus in Chagas disease. Diastolic dysfunction is an important hallmark of Chagas disease even in its early phases. In general, left ventricular diastolic and systolic dysfunction coexist and isolated diastolic dysfunction is uncommon but may be present in patients with the indeterminate form. Right ventricular dysfunction may be detected early in the disease course, but in general, the clinical manifestations occur late at advanced stages of Chagas cardiomyopathy. Several echocardiographic parameters have been used to assess right ventricular function in Chagas disease, including qualitative evaluation, myocardial performance index, tissue Doppler imaging, tricuspid annular plane systolic excursion, and speckle tracking strain. Cardiac magnetic resonance (CMR) is useful to assess global and regional left ventricular function in patients with Chagas diseases. Myocardial fibrosis is a striking feature of Chagas cardiomyopathy and late gadolinium enhancement (LGE) is used to detect and quantify the extension of myocardial fibrosis. Myocardial fibrosis might have a role in risk stratification of patients with Chagas disease. Limited data are available regarding right ventricular function assessed by CMR in Chagas disease. Radionuclide ventriculography is used for global biventricular function assessment in patients with suspected or definite cardiac involvement in Chagas disease with suboptimal acoustic window and contraindication to CMR. Myocardial perfusion scintigraphy may improve risk stratification to define cardiac involvement in Chagas disease, especially in the patients with devices who cannot be submitted to CMR and in the clinical setting of Chagas patients whose main complaint is atypical chest pain. Detection of reversible ischemic defects predicts further deterioration of left ventricular systolic function and helps to avoid unnecessary cardiac catheterization and coronary angiography.

CONCLUSION: Cardiac imaging is crucial to detect the cardiac involvement in patients with Chagas disease, stage the disease and stratify patient risk and address management. Unfortunately, most patients live in regions with limited access to imaging methods and point-of-care, simplified protocols, could improve the access of these remote populations to important information that could impact in the clinical management of the disease. Therefore, there are many fields for further research in cardiac imaging in Chagas disease. How to better provide an earlier diagnosis of cardiac involvement and improve patients risk stratification remains to be addressed using different images modalities.

来源:Eur Heart J Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Nunes MCP, Badano LP, Marin-Neto JA, et al. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI). Eur Heart J Cardiovasc Imaging. 2018. PMID: 29029074. doi:10.1093/ehjci/jex154

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。